Szymczak E, Gajewska J, Laskowska-Klita T
Zakład Biochemii i Diagnostyki Laboratoryjnej Instytutu Matki i Dziecka w Warszawie.
Pol Merkur Lekarski. 2001 Jul;11(61):56-9.
This review briefly summarises the scientific evidence for the child's future risk of ischemic heart diseases (IHD). The conventional risk factors such as dyslipidemia, hypertension, diabetes and smoking can not account for all the cases of cardiovascular diseases. Therefore other risk factors such as fibrinogen, homocysteine, paraoxonaze and abnormality in antioxidant defence systems are included. Among the lipids parameters the level of lipoprotein (a) and increased plasma cholesterol, specifically LDL-cholesterol may be used as a marker of family history of IHD and hypercholesterolemia. Additionally, low level of HDL-cholesterol is also related with endothelial dysfunction and increased oxidative stress. It has been hypothesised that free radicals mediate in the development of IHD and that antioxidants play a protective role in prevention of this pathology. Many of the major risk factors can be modified through diet, body mass control, exercise and (if necessary) through pharmacological intervention. Therefore, the efficacious prevention should be related with the early detection of risk factors particularly in children with familial dyslipidemia, hypertension and IHD.
本综述简要总结了儿童未来患缺血性心脏病(IHD)风险的科学证据。传统的风险因素,如血脂异常、高血压、糖尿病和吸烟,并不能解释所有心血管疾病病例。因此,其他风险因素,如纤维蛋白原、同型半胱氨酸、对氧磷酶和抗氧化防御系统异常也被纳入考虑。在血脂参数中,脂蛋白(a)水平以及血浆胆固醇升高,特别是低密度脂蛋白胆固醇,可作为IHD家族史和高胆固醇血症的标志物。此外,高密度脂蛋白胆固醇水平低也与内皮功能障碍和氧化应激增加有关。据推测,自由基在IHD的发展过程中起介导作用,而抗氧化剂在预防这种病理状况中起保护作用。许多主要风险因素可通过饮食、体重控制、运动以及(如有必要)药物干预来改变。因此,有效的预防应与风险因素的早期检测相关,特别是在患有家族性血脂异常、高血压和IHD的儿童中。